Cardiology in H1 2024
CardiacWire
JUNE 30, 2024
GLP-1s are for CVD too – So far this year GLP-1s have gone from a weight loss and diabetes drug that “might” have cardiovascular benefits to becoming an FDA-approved and Medicare-covered option for CV event reduction.
Let's personalize your content